investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Generation of Highly Avid Anti-Tumor CTL for Optimal Adoptive Immunotherapy

Naoto Hirano

0 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Related projects

Bruce Shapiro

Computational and Experimental RNA Nanobiology

All cancers but non-melanoma skin cancer

Paul Boutros

Systems Biology of Tumour Hypoxia

All cancers but non-melanoma skin cancer

Lewis Kay

CRC Tier 1 - Develop new Nuclear Magnetic Resonance Spectroscopy based techniques for relating molecular motions to function

All cancers but non-melanoma skin cancer

Chantal Guillemette

Pharmacogenomics program identifies genomic changes that affect adverse effects and treatment efficacy (CANADA RESEARCH CHAIRHOLDER - Tier 1)

All cancers but non-melanoma skin cancer

David L Woodland

Stem Cells and Cancer

All cancers but non-melanoma skin cancer

Yun-Xing Wang

SAXS Core

All cancers but non-melanoma skin cancer

Alexandre Orthwein

Importance of cyclin D1-USP11 interaction for the homologous repair pathway

All cancers but non-melanoma skin cancer

Gregg Morin

Recurrent Somatic DICER1 Mutations: Functional Implication and Role in Oncogenesis

All cancers but non-melanoma skin cancer

Mikhail Kashlev

Mechanisms of Transcription Fidelity in Prokaryotes and Eukaryotes

All cancers but non-melanoma skin cancer